CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TLSI — TriSalus Life Sciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TLSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$491,149
+$154,601 QoQ
Shares Held
107,945
+28.3% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 83 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLSI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $9,315,593,237 across 80 Medical Devices names. TLSI ranks #72 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
59,674,507 | $5,414,864,764 | |
| 2 | MDT |
Medtronic plc
|
8,905,319 | $696,663,105 | |
| 3 | SYK |
Stryker Corp
|
2,148,933 | $676,570,065 | |
| 4 | BSX |
Boston Scientific Corp
|
9,223,151 | $393,644,084 | |
| 5 | EW |
Edwards Lifesciences Corp
|
3,693,034 | $334,071,855 | |
| 6 | DXCM |
Dexcom Inc
|
3,439,164 | $231,627,694 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,129,530 | $200,321,215 | |
| 8 | STE |
STERIS plc
|
666,633 | $140,372,910 |
All Filings in TLSI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $491,149 | 107,945 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $336,548 | 84,137 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $698,537 | 100,077 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $266,468 | 57,305 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $272,565 | 50,012 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $55,200 | 10,000 | Shares | Sole | 2025-09-15 | |
| No filing history on record for this holder in this stock. | ||||||